Haemonetics CEO Christopher Simon's 2021 pay slips 8% to $8.6M
Haemonetics reports 2021 executive compensation
By ExecPay News
Published: June 17, 2021
Haemonetics reported fiscal year 2021 executive compensation information on June 17, 2021.
In 2021, five executives at Haemonetics received on average a compensation package of $3.3M, a 7% decrease compared to previous year.
Average pay of disclosed executives at Haemonetics
Christopher Simon, Chief Executive Officer, received $8.6M in total, which decreased by 8% compared to 2020. 59% of Simon's compensation, or $5.1M, was in stock awards. Simon also received $1M in non-equity incentive plan, $1.5M in option awards, $963K in salary, as well as $28K in other compensation.
For fiscal year 2021, the median employee pay was $39,767 at Haemonetics. Therefore, the ratio of Christopher Simon's pay to the median employee pay was 217 to one.
William P. Burke, Chief Financial Officer, received a compensation package of $2.4M, which decreased by 9% compared to previous year. 47% of the compensation package, or $1.1M, was in stock awards.
Michelle L. Basil, General Counsel, earned $2.1M in 2021, a 16% decrease compared to previous year.
Anila Lingamneni, Executive Vice President, Chief Technogy Officer, received $1.8M in 2021.
Josep L. Llorens, Senior Vice President, Global Manufacturing and Supply Chain, earned $1.5M in 2021, a 7% decrease compared to previous year.
Haemonetics' fiscal year ends on April 2.
Related executives
Christopher Simon
Haemonetics
Chief Executive Officer
William Burke
Haemonetics
Chief Financial Officer
Michelle Basil
Haemonetics
General Counsel
Anila Lingamneni
Haemonetics
Executive Vice President, Chief Technogy Officer
Josep Llorens
Haemonetics
Executive Vice President, Global Manufacturing and Supply Chain
You may also like
Source: SEC filing on June 17, 2021.